Althea Group Holdings Limited

AGH

AU0000022774

Pharmaceuticals

Delayed Australian S.E. Other stock markets 02:10:22 2024-06-14 am EDT			5-day change	1st Jan Change
0.021 ^AUD	-8.70%		-12.50%	-46.15%

May. 24	Althea Group Holdings Signs JV to Enter US Cannabis-Infused Drinks Market	MT
May. 23	Althea Group Signs Supply Agreement with Rocket Factory	MT

Althea Group Holdings Limited Announces Revenue Results for the Month of December 2020

January 10, 2021 at 04:25 pm EST

Althea Group Holdings Limited announced revenue results for the month of December 2020. The company recorded sales of $1,190,473 in December 2020, an increase of 40% from November 2020, and the first time monthly sales have exceeded $1 million.

Latest news about Althea Group Holdings Limited

Althea Group Holdings Signs JV to Enter US Cannabis-Infused Drinks Market	May. 23	MT
Althea Group Signs Supply Agreement with Rocket Factory	May. 22	MT
Althea Group Holdings Posts AU$8 Million in Cash Receipts in Fiscal Q3	Apr. 30	MT
Althea Group Signs Distribution Agreement with Symbion	Apr. 21	MT
Althea Group Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 29	CI
European yields rise, Italy's 10-year yield bounces off three-week low	Feb. 26	RE
European yields tick up, Italy's 10-year yield bounces off three-week low	Feb. 26	RE
IT, Real Estate Rally Drives Rebound in Australian Shares	Feb. 02	MT
Althea Group Subsidiary Peak Signs Manufacturing Deal with Collective Project; Shares Up 8%	Feb. 01	MT
Markets stumble into rate-cut waiting room as central banks stand firm	Feb. 01	RE
Hong Kong court convicts four for rioting after 2019 legislature storming	Jan. 31	RE
Althea Group Posts 33% Jump in Fiscal Q2 Receipts from Customers	Jan. 31	MT
Higher Spanish inflation kicks euro zone bond yields off two-week lows	Jan. 30	RE
Althea Group Launches Two Softgel Cannabis Capsules; Shares Up 5%	Jan. 22	MT
Euro zone bond yields drop as economic gloom thickens	Dec. 13	RE
Italian debt in the spotlight as ratings reviews loom	23-10-18	RE
Althea Group to Sell, Lease Back Canada Property for AU$5.3 Million	23-10-17	MT
Euro zone bond yields drop on Middle East conflict	23-10-09	RE
Middle East turmoil ratchets up uncertainty for battered markets	23-10-09	RE
Euro zone bond yields slip ahead of U.S. data	23-10-05	RE
Euro zone bond rout continues as Treasury yields surge to 2007 levels	23-10-04	RE
Italy bond yields surge after budget; German 10-year hits 12-year high	23-09-28	RE
Euro zone bond yields hover near 2-week high on renewed inflation fears	23-09-06	RE
Althea Group Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
1st Group Appoints COO; Shares Jump 22%	23-08-21	MT

Chart Althea Group Holdings Limited

Duration

Period

More charts

Company Profile

Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of recreational cannabis products and cannabis-based medicines. The Company operates through three business units: Althea, MyAccess Clinics and Peak Processing Solutions. Althea and MyAccess Clinics service the international pharmaceutical cannabis market, whilst Peak Processing Solutions operates in the federally legal Canadian recreational cannabis market. The Companyâs segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate). The Pharmaceutical Cannabis includes Althea, a brand of cannabis-based medicine. The Companyâs Recreational Cannabis segment includes Peak Processing Solutions (Peak), a contract manufacturing organization which works with consumer-packaged goods companies to develop, manufacture, and distribute recreational cannabis products.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ALTHEA GROUP HOLDINGS LIMITED	-46.15%	5.7M
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ASTRAZENECA PLC	+18.02%	246B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B

Other Pharmaceuticals